NorA-IN-1

CAS No. 1389310-69-3

NorA-IN-1( —— )

Catalog No. M37304 CAS No. 1389310-69-3

NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 170 In Stock
10MG 275 In Stock
25MG 465 In Stock
50MG 649 In Stock
100MG 900 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NorA-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.
  • Description
    NorA-IN-1 (Compound 16) is a NorA inhibitor. NorA-IN-1 inhibits NorA efflux pump in everted membrane vesicles. NorA-IN-1 can be used for research of multidrug resistance.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1389310-69-3
  • Formula Weight
    314.33
  • Molecular Formula
    C18H18O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C=CC=1C(OC)=CC(OC)=CC1OC)C2=CC=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Holler JG, et al. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg Med Chem. 2012 Jul 15;20(14):4514-21.?
molnova catalog
related products
  • G250.A2

    G250.A2

  • Zederone

    Zederone has anti-bacterial activity,it inhibits gram-positive bacteria activity. Zederone induces hepatotoxicity implicated the induction of Cyps, which leads to the formation of biological reactive metabolites and that cause the oxidative stress and liver cell injuries.

  • Jujuboside D

    Jujuboside D shows lipoxygenase-inhibiting activity.